Pennant Group, Inc. PNTG

Healthcare SIC 8000 - Services-Health Services NAICS Health Care and Social Assistance derived Nasdaq

The Pennant Group, Inc. is a leading provider of high-quality healthcare services to patients, residents, and clients of all ages, including the growing senior population, in the United States. We strive to be the provider of choice in the communities we serve through our innovative operating model and unique core values.

As of December 31, 2025, we operate in multiple lines of business, including home health, hospice, and senior living services across Alabama, Arizona, California, Colorado, Georgia, Idaho, Montana, Nevada, Oklahoma, Oregon, Tennessee, Texas, Utah, Washington, Wisconsin and Wyoming. We also provide home health and hospice operational support through a management service agreement in Connecticut. We provide home health and hospice services through 172 agencies, and senior living services at 63 communities with 4,428 total units in our assisted living, independent living and memory care business. We derive revenue from a diversified blend of payors including Medicare and Medicaid programs, private pay patients and residents, and managed care payors.

Last close 41.88 2026-10-23
Market cap $1.46B 2026-06-30 share count
52-week range 22.25 - 42.74

Valuation FY2025 figures against the last close

P/S1.5x
P/E49.9x
P/FCF40.3x
EV/EBITDA26.8x
Dividend yield—
Diluted EPS0.84

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $947.7M$695.2M$544.9M$473.2M$439.7M$391.0M$338.5M$286.1M$251.0M—
SG&A $71.1M$50.2M$36.7M$34.0M$36.3M—————
Total operating expenses $895.8M$657.1M$519.7M$460.5M$435.0M$372.0M$332.9M$265.4M$235.6M—
Operating income $51.9M$38.1M$25.2M$12.7M$4.7M$18.9M$5.7M$20.6M$15.4M—
Interest expense $6.7M$7.0M$5.9M$3.8M$1.9M$1.2M$410.0K$0——
Pre-tax income $45.6M$31.4M$19.6M$8.9M$2.7M$17.9M$5.3M$20.6M$15.4M—
Income tax $11.9M$7.0M$5.7M$1.6M$582.0K$2.4M$2.1M$4.4M$5.4M—
Net income $29.6M$22.6M$13.4M$6.6M$2.7M$15.7M$2.5M$15.7M$9.9M—
EPS, basic 0.860.720.450.230.090.560.110.580.36—
EPS, diluted 0.840.700.440.220.090.520.110.580.36—
Shares, diluted (wtd. avg.) 35.3M32.0M30.2M30.2M30.6M30.2M29.6M27.8M27.8M—

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $17.0M$24.2M$6.1M$2.1M$5.2M$43.0K$402.0K$41.0K$36.0K$30.0K
Receivables $123.1M$81.3M$61.1M$53.4M$53.9M$47.2M$32.2M$24.5M——
Total current assets $167.4M$122.9M$80.1M$73.8M$75.8M$59.6M$38.7M$29.1M——
Property, plant and equipment $61.0M$43.3M$28.6M$26.6M$16.8M$17.9M$14.6M$10.5M——
Goodwill $237.2M$129.1M$91.0M$79.5M$74.3M$66.4M$41.2M$30.9M$28.0M—
Other intangibles ——————$45.0K$78.0K——
Total assets $968.2M$679.5M$539.7M$512.1M$530.3M$507.0M$447.8M$98.2M——
Accounts payable $25.2M$18.7M$10.8M$13.6M$10.6M$9.8M$8.7M$4.4M——
Short-term debt $5.0M$0————————
Total current liabilities $147.3M$101.7M$71.5M$70.2M$71.6M$89.0M$51.2M$29.5M——
Long-term debt $168.8M$0$63.9M$62.9M$51.4M$8.3M$18.5M$0——
Total liabilities $593.9M$367.6M$394.2M$386.5M$416.1M$405.8M$376.6M$32.9M——
Retained earnings $86.8M$57.2M$34.7M$21.3M$14.6M$11.9M-$3.8M$0——
Total equity $374.3M$312.0M$145.5M$125.7M$114.2M$101.2M$71.1M$65.3M$59.9M$48.4M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $48.3M$39.3M$33.1M$9.0M-$18.2M$50.2M$9.6M$23.3M$17.2M—
Depreciation and amortisation $8.5M$6.1M$5.1M$4.9M$4.8M$4.7M$3.8M$3.0M$2.5M—
Stock-based compensation $8.9M$7.8M$5.4M$3.1M$10.0M$8.3M$3.4M$2.4M$2.3M—
Capital expenditure $12.0M$9.0M$8.1M$14.2M$6.3M$7.3M$6.7M$3.6M$3.1M—
Investing cash flow -$228.0M-$70.7M-$30.2M-$24.2M-$20.1M-$41.6M-$26.5M-$9.5M-$16.1M—
Financing cash flow $172.5M$49.6M$1.1M$12.1M$43.5M-$8.9M$17.3M-$13.8M-$1.2M—
Dividends paid ————$0$0$11.6M$0$0—
Buybacks ———$0$0$65.0K$0$0——

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001766400-26-000014.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. 0 250M 500M 750M 1B Revenue, FY2017: 251M Net income, FY2017: 9.9M Revenue, FY2018: 286.1M Net income, FY2018: 15.7M Revenue, FY2019: 338.5M Net income, FY2019: 2.5M Revenue, FY2020: 391M Net income, FY2020: 15.7M Revenue, FY2021: 439.7M Net income, FY2021: 2.7M Revenue, FY2022: 473.2M Net income, FY2022: 6.6M Revenue, FY2023: 544.9M Net income, FY2023: 13.4M Revenue, FY2024: 695.2M Net income, FY2024: 22.6M Revenue, FY2025: 947.7M Net income, FY2025: 29.6M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue — $251.0M $286.1M $338.5M $391.0M $439.7M $473.2M $544.9M $695.2M $947.7M
Gross profit — — — — — — — — — —
Net income — $9.9M $15.7M $2.5M $15.7M $2.7M $6.6M $13.4M $22.6M $29.6M

Recent filings and events

  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Results announced Item 2.02
  • Regulation FD disclosure Item 7.01
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Results announced Item 2.02
  • Regulation FD disclosure Item 7.01
  • Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
  • Results announced Item 2.02
  • New debt or obligation The company has taken on debt or a comparable obligation. Item 2.03
  • Regulation FD disclosure Item 7.01

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 8000

TickerCompanyMarket capP/ERevenue growth
LFST LifeStance Health Group, Inc. $4.94B — 13.9%
PRVA Privia Health Group, Inc. $2.86B 124.5x 22.3%
WGS GeneDx Holdings Corp. $1.67B — 40.0%
USPH U S PHYSICAL THERAPY INC /NV $1.32B 62.3x 16.3%
INNV InnovAge Holding Corp. $1.30B — 11.8%
OMDA Omada Health, Inc. $1.16B — 53.2%
SRTA Strata Critical Medical, Inc. $412.3M 9.3x 34.3%
DCGO DocGo Inc. $26.8M — -47.7%